Ignite Creation Date:
2024-05-06 @ 8:24 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06364046
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-04-15
First Post:
2024-03-14
Brief Title:
Efficacy and Safety of DEB-BACE Combined With Serplulimab in First-line Treatment of SCLC
Sponsor:
The Central Hospital of Lishui City
Organization:
The Central Hospital of Lishui City
Study Overview
Official Title:
Efficacy and Safety of DEB-BACE Combined With Serplulimab in First-line Treatment of SCLCA Prospective Single-center Randomized Open Double-arm Clinical Trial
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This project aims to conduct a prospective single-center randomized open-label two-arm study to compare the clinical efficacy and safety of bronchial arterial chemoembolization with drug-eluting beads DEB-BACE combined with serplulimab versus conventional intravenous chemotherapy combined with Serplulimab as first-line treatment for SCLC patients The objective is to provide evidence-based support for clinical practice
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None